Differential serum proteome profiling and electrochemical biosensing of leucine-rich alpha-2-glycoprotein (LRG1) and lipopolysaccharide-binding protein (LBP) as subtype-specific biomarkers for HPV-negative cervical cancer
Background Cervical cancer (CC) is still a major global health concern. Specifically, human papillomavirus (HPV) - negative CC (HPV-neg CC) has a poorer prognosis than HPV-positive cases (HPV-pos CC). Distinguishing between HPV-pos and HPV-neg CC is the focus of this study, using proteomics and electrochemical biosensors. Methods Pooled serum samples from healthy individuals, HPV-pos CC, and HPV-neg CC patients were analyzed using label-free quantitative proteomics. Differentially expressed proteins (DEPs) were analyzed using PEAKS ® Studio software (≤1% False Discovery Rate, FDR; 1.5-fold change threshold). STRING and Metascape databases were used for protein-protein interaction analysis and functional clustering. An electrochemical impedance spectroscopy (EIS) biosensor was developed to quantify potential candidate biomarkers including lipopolysaccharide-binding protein (LBP) and leucine-rich alpha-2-glycoprotein (LRG1). Results Proteomics revealed distinct signatures, associating HPV-pos and HPV-neg CC with humoral immune response impairment and systemic inflammatory response, respectively. Concurrently, inflammatory mediators, LBP and LRG1 were top DEPs across all groups, with 3.99 and 2.89-fold increases in HPV-neg CC vs. healthy control, respectively. The EIS-based biosensor verified that LBP had remarkable discriminatory power in separating HPV-pos CC cases from HPV-neg CC cases (AUC = 0.9815), whereas LRG1 successfully separated cancer cases from healthy controls (AUC = 1.000). Conclusions Proteomics and EIS biosensor techniques identified LBP as a potential biomarker linked to systemic inflammatory responses in HPV-neg CC. Therefore, this pilot study links the gap between proteomic discovery and clinical application, eventually providing exploratory insights into subtype characterization for HPV-neg CC. Further investigations in a larger cohort based on our findings are necessary for a better understanding of the role of LBP and LRG1 in all CC subtypes.
Authors
- Juthamard Chantaraamporn (ORCID: https://orcid.org/0009-0005-3124-6155)
- Churat Weeraphan (ORCID: https://orcid.org/0009-0009-7020-5910)
- Theetat Ruangjaroon
- Jisnuson Svasti (ORCID: https://orcid.org/0000-0002-2217-4517)
- Chantragan Srisomsap (ORCID: https://orcid.org/0000-0003-3919-2380)
- Penchatr Diskul‐Na‐Ayudthaya (ORCID: https://orcid.org/0009-0003-3521-4009)
- Daranee Chokchaichamnankit (ORCID: https://orcid.org/0000-0002-5084-8259)
- Narongrit Sritana (ORCID: https://orcid.org/0009-0008-3663-0414)
- Kamolwan Watcharatanyatip
- Nuttavut Kantathavorn (ORCID: https://orcid.org/0000-0002-2056-866X)
- Amita Mekarunothai
Institutions
- Chulabhorn Graduate Institute (TH)
- Chulabhorn Research Institute (TH)
- Chulabhorn Hospital (TH)
- Chulabhorn Royal Academy (TH)
- HRH Princess Chulabhorn College of Medical Science (TH)
Publication Details
- Journal
- PeerJ
- Published
- 2026-11-18
- DOI
- https://doi.org/10.7717/peerj.21759
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chulabhorn Research Institute
- Thailand Science Research and Innovation